The results led to the conclusion that MMP-2 overexpression by cancer cells in peritoneal implants, but not in primary ovarian cancer, is predictive of ovarian cancer prognosis and more likely reflects the presence of highly aggressive clones of cancer cells [47]. This evidence concerns the gene MMP2 and ovarian carcinoma.